ArticleAdvanced pharmaceutical bulletin2025
Predatory Medical Journals in Patent Literature: A Hidden Threat.
Article in Advanced pharmaceutical bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The negative impact of potential predatory journals has been widely discussed, primarily within academic contexts. However, their influence beyond academia remains underexplored. This study aims to address that gap. Methods: The current editorial utilised a sample list of 8 potential predatory medical journals. We compiled a list of potential predatory medical journals using the discontinued titles list in Scopus and the current blocklists. Then their patent-to-paper citations have been examined to understand the dissemination of questionable medical publications outside of academia. Results: This indicates that potential predatory medical journals received 483,848 citations from scholarly works and 4,251 citations from patents. Conclusion: When patents cite papers from predatory journals, flawed information may propagate, or potentially leading to wrongful patent rejections and wasted resources. This serves as a warning for the patent community to take action against potential predatory journals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.